Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification.
Saved in:
| Title: | Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification. |
|---|---|
| Authors: | Goddard J; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK., Castle J; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK., Southworth E; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK., Fletcher A; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK., Crosier S; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK., Martin-Guerrero I; Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.; Department of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country, Leioa, Spain., García-Ariza M; Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.; Department of Pediatric Hematology and Oncology, Cruces University Hospital, Barakaldo, Spain., Navajas A; Biocruces Bizkaia Health Research Institute, Barakaldo, Spain., Masliah-Planchon J; Unité de Génétique Somatique, Institut Curie, Paris, France., Bourdeaut F; SIREDO Pediatric Oncology Center, Curie Institute, Paris, France., Dufour C; Department of Pediatric and Adolescent Oncology, Gustave Roussy, Rue Edouard Vaillant, 94805, Villejuif, France., Ayrault O; UMR 3347, INSERM U1021, Institut Curie, PSL Research University, Université Paris Sud, Université Paris-Saclay, CNRS, Paris, France., Goschzik T; Department of Neuropathology, DGNN Brain Tumour Reference Center, University of Bonn Medical Center, Bonn, Germany., Pietsch T; Department of Neuropathology, DGNN Brain Tumour Reference Center, University of Bonn Medical Center, Bonn, Germany., Sill M; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany., Pfister SM; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Paediatric Haematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany., Rutkowski S; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Richardson S; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK., Hill RM; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK., Williamson D; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK., Bailey S; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK., Schwalbe EC; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK.; Department of Applied Sciences, Northumbria University, Newcastle Upon Tyne, UK., Clifford SC; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK. steve.clifford@ncl.ac.uk., Hicks D; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK. debbie.hicks@newcastle.ac.uk. |
| Source: | Acta neuropathologica [Acta Neuropathol] 2023 May; Vol. 145 (5), pp. 651-666. Date of Electronic Publication: 2023 Apr 04. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0412041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0533 (Electronic) Linking ISSN: 00016322 NLM ISO Abbreviation: Acta Neuropathol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37014508 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Goddard+J%22">Goddard J</searchLink>; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Castle+J%22">Castle J</searchLink>; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Southworth+E%22">Southworth E</searchLink>; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Fletcher+A%22">Fletcher A</searchLink>; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Crosier+S%22">Crosier S</searchLink>; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Martin-Guerrero+I%22">Martin-Guerrero I</searchLink>; Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.; Department of Genetics, Physical Anthropology and Animal Physiology, University of the Basque Country, Leioa, Spain.<br /><searchLink fieldCode="AU" term="%22García-Ariza+M%22">García-Ariza M</searchLink>; Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.; Department of Pediatric Hematology and Oncology, Cruces University Hospital, Barakaldo, Spain.<br /><searchLink fieldCode="AU" term="%22Navajas+A%22">Navajas A</searchLink>; Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.<br /><searchLink fieldCode="AU" term="%22Masliah-Planchon+J%22">Masliah-Planchon J</searchLink>; Unité de Génétique Somatique, Institut Curie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Bourdeaut+F%22">Bourdeaut F</searchLink>; SIREDO Pediatric Oncology Center, Curie Institute, Paris, France.<br /><searchLink fieldCode="AU" term="%22Dufour+C%22">Dufour C</searchLink>; Department of Pediatric and Adolescent Oncology, Gustave Roussy, Rue Edouard Vaillant, 94805, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Ayrault+O%22">Ayrault O</searchLink>; UMR 3347, INSERM U1021, Institut Curie, PSL Research University, Université Paris Sud, Université Paris-Saclay, CNRS, Paris, France.<br /><searchLink fieldCode="AU" term="%22Goschzik+T%22">Goschzik T</searchLink>; Department of Neuropathology, DGNN Brain Tumour Reference Center, University of Bonn Medical Center, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Pietsch+T%22">Pietsch T</searchLink>; Department of Neuropathology, DGNN Brain Tumour Reference Center, University of Bonn Medical Center, Bonn, Germany.<br /><searchLink fieldCode="AU" term="%22Sill+M%22">Sill M</searchLink>; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Pfister+SM%22">Pfister SM</searchLink>; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Paediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Paediatric Haematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Rutkowski+S%22">Rutkowski S</searchLink>; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Richardson+S%22">Richardson S</searchLink>; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Hill+RM%22">Hill RM</searchLink>; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Williamson+D%22">Williamson D</searchLink>; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Bailey+S%22">Bailey S</searchLink>; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Schwalbe+EC%22">Schwalbe EC</searchLink>; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK.; Department of Applied Sciences, Northumbria University, Newcastle Upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Clifford+SC%22">Clifford SC</searchLink>; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK. steve.clifford@ncl.ac.uk.<br /><searchLink fieldCode="AU" term="%22Hicks+D%22">Hicks D</searchLink>; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK. debbie.hicks@newcastle.ac.uk. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220412041%22">Acta neuropathologica</searchLink> [Acta Neuropathol] 2023 May; Vol. 145 (5), pp. 651-666. <i>Date of Electronic Publication: </i>2023 Apr 04. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Verlag%22">Springer Verlag </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>0412041 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1432-0533 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200016322%22">00016322 </searchLink><i>NLM ISO Abbreviation: </i>Acta Neuropathol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37014508 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s00401-023-02566-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 651 Titles: – TitleFull: Molecular characterisation defines clinically-actionable heterogeneity within Group 4 medulloblastoma and improves disease risk-stratification. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Goddard J – PersonEntity: Name: NameFull: Castle J – PersonEntity: Name: NameFull: Southworth E – PersonEntity: Name: NameFull: Fletcher A – PersonEntity: Name: NameFull: Crosier S – PersonEntity: Name: NameFull: Martin-Guerrero I – PersonEntity: Name: NameFull: García-Ariza M – PersonEntity: Name: NameFull: Navajas A – PersonEntity: Name: NameFull: Masliah-Planchon J – PersonEntity: Name: NameFull: Bourdeaut F – PersonEntity: Name: NameFull: Dufour C – PersonEntity: Name: NameFull: Ayrault O – PersonEntity: Name: NameFull: Goschzik T – PersonEntity: Name: NameFull: Pietsch T – PersonEntity: Name: NameFull: Sill M – PersonEntity: Name: NameFull: Pfister SM – PersonEntity: Name: NameFull: Rutkowski S – PersonEntity: Name: NameFull: Richardson S – PersonEntity: Name: NameFull: Hill RM – PersonEntity: Name: NameFull: Williamson D – PersonEntity: Name: NameFull: Bailey S – PersonEntity: Name: NameFull: Schwalbe EC – PersonEntity: Name: NameFull: Clifford SC – PersonEntity: Name: NameFull: Hicks D IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2023 May Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1432-0533 Numbering: – Type: volume Value: 145 – Type: issue Value: 5 Titles: – TitleFull: Acta neuropathologica Type: main |
| ResultId | 1 |